A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Clinical trial NCT02875223 · TERMINATED
Trial details
- NCT number
- NCT02875223
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-31
- Primary completion
- 2024-03-25
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.